Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Death signals changes in TFIID.

G Gill1

  • 1Department of Pathology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA.

Molecular Cell
|October 5, 2001
PubMed
Summary
This summary is machine-generated.

Researchers discovered a new form of hTAF(II)80 activated by cell death signals. This finding shows how general transcription factors

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of surgical versus non-surgical treatment of resectable T<sub>4</sub>a laryngeal and hypopharyngeal carcinoma.

The Journal of laryngology and otology·2022
Same author

Longitudinal health utilities, symptoms and toxicities in patients with <i>ALK-</i>rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment.

Current oncology (Toronto, Ont.)·2020
Same author

Assessing impact of organised breast screening across small residential areas-development and internal validation of a prediction model.

European journal of cancer care·2017
Same author

A report on emergent uranyl binding phenomena by an amidoxime phosphonic acid co-polymer.

Physical chemistry chemical physics : PCCP·2016
Same author

Primum non nocere. Resist the urge to treat.

QJM : monthly journal of the Association of Physicians·2016
Same author

Fine Needle Aspiration Cytology vs. the Postoperative Histology - the Continuing Need for Multi-Disciplinary Approach?

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2016
Same journal

Thyroid cancer-associated EZH1 Q571R mutation drives chromatin compaction and H3K27me3 invasion into active chromatin.

Molecular cell·2026
Same journal

Genome-wide rotational and translational phasing of nucleosomes with human transcription factors.

Molecular cell·2026
Same journal

Spliceosomal proofreading factors safeguard 3' splice-site fidelity and prevent proteotoxicity and inflammation.

Molecular cell·2026
Same journal

Cytosolic EZH2-IMPDH2 complexes regulate melanoma progression and metastasis via GTP.

Molecular cell·2026
Same journal

A bacterial reverse transcriptase: Protein-templated DNA synthesis fuels antiviral immunity.

Molecular cell·2026
Same journal

Tweezing apart ribosome heterogeneity.

Molecular cell·2026
See all related articles

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • The general transcription factor TFIID plays a crucial role in gene expression.
  • Understanding the regulation of TFIID composition is key to deciphering inducible gene programs.

Discussion:

  • Bell et al. report the identification of a novel isoform of human TAF(II)80 (hTAF(II)80).
  • This isoform is specifically induced upon exposure to various proapoptotic stimuli.
  • The study links extracellular signals to alterations in the TFIID complex's subunit makeup.

Key Insights:

  • Extracellular proapoptotic signals can trigger the induction of a specific hTAF(II)80 isoform.
  • This isoform induction alters the subunit composition of the TFIID complex.
  • Regulated changes in general transcription factor activity are implicated in inducible gene expression.

Related Experiment Videos

Outlook:

  • Further investigation into the functional role of this hTAF(II)80 isoform in apoptosis and gene regulation is warranted.
  • This discovery opens new avenues for understanding how cells respond to death signals at the transcriptional level.
  • Exploring therapeutic strategies targeting TFIID composition in disease.